SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Cheung AN. Pathology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003; 17: 849868.
  • 2
    Shih IM, Mazur MT, Kurman RJ. Gestational trophoblastic disease and related lesion. In: KurmanRJ, editor. Blaustein's pathology of the female genital tract. (5th ed). New York: Springer, 2002: 11931250.
  • 3
    Paradinas FJ, Elston CW. Gestational trophoblastic diseases. In: FoxH, WellsM, editors. Haines & Taylor obstetrical and gynaecological pathology. (5th ed). Edinburgh: Churchill Livingstone, 2003: 13591430.
  • 4
    Wong LC, Ngan HY, Cheng DK, Ng TY. Methotrexate infusion in low-risk gestational trophoblastic disease. Am J Obstet Gynecol. 2000; 183: 15791582.
  • 5
    Ng TY, Wong LC. Diagnosis and management of gestational trophoblastic neoplasia. Best Pract Res Clin Obstet Gynaecol. 2003; 17: 893903.
  • 6
    Soper JT, Mutch DG, Schink JC. Diagnosis and treatment of gestational trophoblastic disease: ACOG practice bulletin no. 53. Gynecol Oncol. 2004; 93: 575585.
  • 7
    Wong SY, Ngan HY, Chan CC, Cheung AN. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression. Mod Pathol. 1999; 12: 10251033.
  • 8
    Chiu PM, Ngan YS, Khoo US, Cheung AN. Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody. Histopathology. 2001; 38: 243249.
  • 9
    Cheung AN, Zhang DK, Liu Y, Ngan HY, Shen DH, Tsao SW. Telomerase activity in gestational trophoblastic disease. J Clin Pathol. 1999; 52: 588592.
  • 10
    Fong PY, Xue WC, Ngan HY, et al. Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome. Cancer. 2005; 103: 268276.
  • 11
    Feng HC, Tsao SW, Ngan HY, et al. Differential gene expression identified in complete hydatidiform mole by combining suppression subtractive hybridization and cDNA microarray. Placenta. 2005; Jul 16:[Epub ahead of print].
  • 12
    Diatchenko L, Lau YF, Campbell AP, et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A. 1996; 93: 60256030.
  • 13
    Kwok Fung LA, Liu Y, Wang X, et al. Identification of downstream target genes of latent membrane protein 1 in nasopharyngeal carcinoma cells by suppression subtractive hybridization. Biochim Biophys Acta. 2001; 1520: 131140.
  • 14
    Lai CY, Chan KY, Khoo US, et al. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization. Mod Pathol. 2004; 17: 4048.
  • 15
    Cheung AN, Khoo US, Lai CY, et al. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis. Cancer. 2004; 100: 14111417.
  • 16
    Kwok Fung Lo A, Liu Y, Wang X, et al. Identification of downstream target genes of latent membrane protein 1 in nasopharyngeal carcinoma cells by suppression subtractive hybridization. Biochim Biophys Acta. 2001; 1520: 131140.
  • 17
    Feng HC, Choy MY, Deng W, et al. Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1). J Soc Gynecol Investig. 2005; 12: e2132.
  • 18
    Patel P, Boyd CA, Johnston DG, Williamson C. Analysis of GAPDH as a standard for gene expression quantification in human placenta. Placenta. 2002; 23: 697698.
  • 19
    Feng H, Cheung AN, Xue WC, et al. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma. Gynecol Oncol. 2004; 94: 375382.
  • 20
    Bo M, Boime I. Identification of the transcriptionally active genes of the chorionic gonadotropin beta gene cluster in vivo. J Biol Chem. 1992; 267: 31793184.
  • 21
    Xu RH, Chen X, Li DS, et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol. 2002; 20: 12611264.
  • 22
    GeneAmp 5700 user's manual. Absolute and relative quantitation. Foster City, CA: PE Applied Biosystems, 1998.
  • 23
    Irving JA, Lala PK. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1. Exp Cell Res. 1995; 217: 419427.
  • 24
    Hamilton GS, Lysiak JJ, Han VK, Lala PK. Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp Cell Res. 1998; 244: 147156.
  • 25
    Gleeson LM, Chakraborty C, McKinnon T, Lala PK. Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein kinase pathway. J Clin Endocrinol Metab. 2001; 86: 24842493.
  • 26
    McKinnon T, Chakraborty C, Gleeson LM, Chidiac P, Lala PK. Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab. 2001; 86: 36653674.
  • 27
    Irwin JC, Giudice LC. Insulin-like growth factor binding protein-1 binds to placental cytotrophoblast alpha5beta1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures. Growth Horm IGF Res. 1998; 8: 2131.
  • 28
    Giudice LC, Martina NA, Crystal RA, Tazuke S, Druzin M. Insulin-like growth factor binding protein-1 at the maternal–fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol. 1997; 176: 751757.
  • 29
    Fisher RA, Hodges MD. Genomic imprinting in gestational trophoblastic disease–a review. Placenta. 2003; 24(Suppl A): S111S118.
  • 30
    Netzel-Arnett S, Mitola DJ, Yamada SS, et al. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity. J Biol Chem. 2002; 277: 4515445161.
  • 31
    Johnson GA, Burghardt RC, Spencer TE, Newton GR, Ott TL, Bazer FW. Ovine osteopontin: II. Osteopontin and alpha(v)beta(3) integrin expression in the uterus and conceptus during the periimplantation period. Biol Reprod. 1999; 61: 892899.
  • 32
    Batorfi J, Fulop V, Kim JH, et al. Osteopontin is down-regulated in hydatidiform mole. Gynecol Oncol. 2003; 89: 134139.
  • 33
    Xue WC, Chan KY, Feng HC, et al. Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma. J Mol Diagn. 2004; 6: 326334.
  • 34
    Drysdale JW. Microheterogeneity in ferritin molecules. Biochim Biophys Acta. 1970; 207: 256258.
  • 35
    Fang R, Aust AE. Induction of ferritin synthesis in human lung epithelial cells treated with crocidolite asbestos. Arch Biochem Biophys. 1997; 340: 369375.
  • 36
    Maymon R, Weinraub Z, Bukovsky I, Moroz C. Placental isoferritin levels during first trimester of normal and complete molar gestations. Placenta. 1995; 16: 455460.
  • 37
    Algarra I, Cabrera T, Garrido F. The HLA crossroad in tumor immunology. Hum Immunol. 2000; 61: 6573.
  • 38
    Ngan HY. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2004; 14: 202205.
  • 39
    Liu VW, Shi HH, Cheung AN, et al. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res. 2001; 61: 59986001.
  • 40
    Liu VW, Yang HJ, Wang Y, et al. High frequency of mitochondrial genome instability in human endometrial carcinomas. Br J Cancer. 2003; 89: 697701.
  • 41
    Chiu PM, Liu VW, Ngan HY, Khoo US, Cheung AN. Detection of mitochondrial DNA mutations in gestational trophoblastic disease. Hum Mutat. 2003; 22: 177185.
    Direct Link:
  • 42
    Wulbrand U, Remmert G, Zofel P, Wied M, Arnold R, Fehmann HC. mRNA expression patterns of insulin-like growth factor system components in human neuroendocrine tumours. Eur J Clin Invest. 2000; 30: 729739.
  • 43
    Pattyn F, Speleman F, De Paepe A, Vandesompele J. RTPrimerDB: the real-time PCR primer and probe database. Nucleic Acids Res. 2003; 31: 122123.